Cutia Therapeutics (HKG:2487)
Hong Kong · Delayed Price · Currency is HKD 4.750
-0.090 (-1.86%)
Apr 17, 2026, 3:41 PM HKT
Cutia Therapeutics Market Cap
Cutia Therapeutics has a market cap or net worth of 1.76 billion as of April 17, 2026. Its market cap has decreased by -7.99% in one year.
Market Cap
1.76B
Enterprise Value
1.23B
Revenue
374.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.75
Market Cap Chart
Since June 12, 2023, Cutia Therapeutics's market cap has decreased from 6.67B to 1.76B, a decrease of -73.65%. That is a compound annual growth rate of -37.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.73B | 4.63% |
| Dec 31, 2025 | 1.65B | -26.86% |
| Dec 31, 2024 | 2.26B | -32.43% |
| Dec 29, 2023 | 3.34B | -49.98% |
| Jun 12, 2023 | 6.67B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SinoMab BioScience | 2.34B |
| Immunotech Biopharm | 2.21B |
| Frontage Holdings | 2.07B |
| HighTide Therapeutics | 2.05B |
| Mabpharm | 1.88B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.69B |
| Zhaoke Ophthalmology | 1.67B |
| CANbridge Pharmaceuticals | 1.57B |